Wall Street Analysts Think LifeStance Health (LFST) Could Surge 30.49%: Read This Before Placing a Bet

The mean of analysts' price targets for LifeStance Health (LFST) points to a 30.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Nov 28, 2025

Wall Street Analysts See a 33.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 33.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Nov 12, 2025

LifeStance Health Group, Inc. (LFST) Q3 2025 Earnings Call Transcript

LifeStance Health Group, Inc. ( LFST ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Monica Prokocki - Vice President of Investor Relations David Bourdon - CEO & Director Ryan McGroarty - CFO & Treasurer Conference Call Participants Craig Hettenbach - Morgan Stanley, Research Division Lisa Gill - JPMorgan Chase & Co, Research Division Matthew Mardula Brian Tanquilut - Jefferies LLC, Research Division Richard Close - Canaccord Genuity Corp., Research Division Kevin Caliendo - UBS Investment Bank, Research Division David Larsen - BTIG, LLC, Research Division Steven Dechert - KeyBanc Capital Markets Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. My name is Colby, and I'll be your conference operator today.

Seeking Alpha • Nov 6, 2025

LifeStance Reports Third Quarter 2025 Results

SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025.

GlobeNewsWire • Nov 6, 2025

LifeStance Health Group (LFST) Reports Break-Even Earnings for Q3

LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season

LifeStance Survey Reveals How the Holidays Affect Mental Health, with Stress and Social Pressure Hitting Millennials and Gen Z Hardest SCOTTSDALE, Ariz. , Nov. 5, 2025 /PRNewswire/ -- Findings from a LifeStance Health survey released today reveal that for many Americans, the holiday season involves a complex mix of emotions, including reported feelings of stress and pressure.

PRNewsWire • Nov 5, 2025

Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care

Collaboration Will Simplify and Streamline Users' Ability to Find Personalized Care Delivered by Licensed Mental Health Clinicians PALO ALTO, Calif. and SCOTTSDALE, Ariz.

PRNewsWire • Oct 28, 2025

LifeStance to Present at the UBS Global Healthcare Conference

SCOTTSDALE, Ariz., Oct. 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming UBS Global Healthcare Conference, which will be hosted in Palm Beach Gardens, FL.

GlobeNewsWire • Oct 28, 2025

LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

SCOTTSDALE, Ariz., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2025 earnings release before the market opens on Thursday, November 6, 2025.

GlobeNewsWire • Oct 16, 2025

All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research • Oct 8, 2025